Mustang Bio (NASDAQ:MBIO) has announced it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line for the company’s MB-107 lentiviral gene therapy program for X-linked severe combined immunodeficiency (XSCID). As quoted in the press release: MB-107 is currently being assessed in two Phase 1/2 clinical trials for XSCID: …
Mustang Bio (NASDAQ:MBIO) has announced it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line for the company’s MB-107 lentiviral gene therapy program for X-linked severe combined immunodeficiency (XSCID).
As quoted in the press release:
MB-107 is currently being assessed in two Phase 1/2 clinical trials for XSCID: the first in newly-diagnosed infants under the age of two (ClinicalTrials.gov Identifier: NCT01512888) and the second in patients over the age of two who have received prior hematopoietic stem cell transplantation (ClinicalTrials.gov Identifier: NCT01306019). Positive Phase 1/2 clinical data from the trial for infants under the age of two were published in the New England Journal of Medicine in April. The U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to MB-107 for the treatment of XSCID earlier this month.
Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “We are pleased to execute this agreement with CSL Behring to bring its Cytegrity™ stable producer cell line to Mustang’s manufacturing facility. The Cytegrity™ stable producer cell line is critical to producing the viral vector for MB-107 as we prepare for commercialization and is an important competitive advantage vis-à-vis programs that use a conventional transient system for vector production. We plan to meet with the FDA later this year to achieve agreement on our regulatory path forward and expect to transfer sponsorship of the IND from St. Jude to Mustang by year-end.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1803.13 | -3.74 | |
Silver | 20.06 | -0.19 | |
Copper | 3.65 | -0.06 | |
Palladium | 1929.64 | +7.64 | |
Platinum | 898.36 | +1.36 | |
Oil | 105.76 | 0.00 | |
Heating Oil | 3.85 | +0.02 | |
Natural Gas | 5.71 | +0.28 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.